Consensus Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
31.94 ^CNY	-2.56%		+2.44%	+12.35%

Jan. 14	Pharmaron Beijing to place 58.4 million new H shares at RMB1.00 per share	RE
Jan. 14	Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering	MT

Evolution of the Average Target: Pharmaron Beijing Co., Ltd.

Evolution of the Target Price: Pharmaron Beijing Co., Ltd.

Changes in Analyst Recommendations: Pharmaron Beijing Co., Ltd.

2748252db8910ec1b2703f.NcEYazjVa_dogZQIcCDTtybS1HBNhBbQaf_Q05ak0yo.bPB8HEqwDYIK29VEEkvk6FOg4D4a4UySKq_pkNKdoGNBt01fC4AYwifxzQ~fbee9e390ede7af593d5a3f87cf1de13

Analysts' recommendations: Pharmaron Beijing Co., Ltd.

25-08-25	Jefferies Adjusts Pharmaron Beijing's Price Target to HK$28 From HK$22, Keeps at Buy	MT
25-08-22	Nomura Adjusts Pharmaron Beijing's Price Target to 34.62 Yuan From 33.75 Yuan, Keeps at Buy	MT
25-08-22	Nomura Adjusts Pharmaron Beijing's Price Target to HK$26.63 From HK$25.86, Keeps at Buy	MT
25-07-16	Nomura Adjusts Pharmaron Beijing's Price Target to 33.75 Yuan From 33.31 Yuan, Keeps at Buy	MT
25-07-16	Nomura Adjusts Pharmaron Beijing's Price Target to HK$25.86 From HK$16.19, Keeps at Buy	MT
25-04-28	Nomura Adjusts Pharmaron Beijing's Price Target to HK$16.19 From HK$14.31, Keeps at Buy	MT
25-04-28	Nomura Adjusts Pharmaron Beijing's Price Target to 33.31 Yuan From 29.73 Yuan, Keeps at Buy	MT
24-08-28	Nomura Adjusts Pharmaron Beijing's Price Target to 29.73 Yuan From 31.41 Yuan, Keeps at Buy	MT
24-08-28	Nomura Adjusts Pharmaron Beijing's Price Target to HK$14.31 From HK$15.41, Keeps at Buy	MT
24-04-29	Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy	MT
24-04-26	Nomura Adjusts Pharmaron Beijing Co's Price Target to HK$15.41 From HK$17.99, Keeps at Buy	MT
24-03-06	Nomura Adjusts Pharmaron Beijing’s Price Target to HK$17.99 From HK$30.92, Keeps at Buy	MT
23-10-25	Nomura Adjusts Pharmaron’s Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy	MT
23-07-24	Nomura Adjusts Pharmaron’s Price Target to 66.94 Yuan From 73.38 Yuan, Keeps at Buy	MT
23-07-24	Nomura Adjusts Pharmaron’s Price Target to HK$36.24 From HK$40.03, Keeps at Buy	MT
23-04-28	Nomura Adjusts Pharmaron’s Price Target to 73.38 Yuan From 85.63 Yuan, Keeps at Buy	MT
23-04-28	Nomura Adjusts Pharmaron's Price Target to HK$60.04 From HK$69.02, Keeps at Buy	MT
23-02-15	Nomura Adjusts Pharmaron Beijing's Price Target to HK$69.02 From HK$62.19, Keeps at Buy	MT
23-02-15	Nomura Adjusts Pharmaron Beijing's Price Target to 85.63 Yuan From 90.01 Yuan, Keeps at Buy	MT
22-10-28	Nomura Adjusts Pharmaron Beijing's Price Target to 90.01 Yuan From 99.95 Yuan, Keeps at Buy	MT
22-10-28	Nomura Adjusts Pharmaron Beijing's Price Target to HK$62.19 From HK$91.89, Keeps at Buy	MT
22-07-19	Nomura Adjusts Pharmaron Beijing's Price Target to 99.95 Yuan From 103.74 Yuan, Keeps at Buy	MT
22-07-19	Nomura Adjusts Pharmaron Beijing's Price Target to HK$91.89 From HK$94.89, Keeps at Buy	MT
22-04-01	UBS Adjusts Pharmaron’s Price Target to HK$149 From HK$240, Keeps at Buy	MT
22-03-11	Nomura Adjusts Pharmaron Beijing's Price Target to HK$141.62 From HK$178.52, Keeps at Buy	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	PHARMARON BEIJING CO., LTD.					+11.8%
	LONZA GROUP AG					+20.19%
	IQVIA HOLDINGS INC.					+7.61%
	BEONE MEDICINES AG					+19.67%
	CELLTRION, INC.					+12%
	REVOLUTION MEDICINES, INC.					-26.18%
	MEDPACE HOLDINGS, INC.					-11.7%
	EUROFINS SCIENTIFIC SE					-6.36%
	ICON PUBLIC LIMITED COMPANY					+12.67%
	Average					+4.41%
	Weighted average by Cap.					+7.46%